Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options
S Karakonstantis, EI Kritsotakis… - Journal of Antimicrobial …, 2020 - academic.oup.com
Background The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach …
The management of carbapenem-resistant infections is often based on polymyxins,
tigecycline, aminoglycosides and their combinations. However, in a recent systematic …
tigecycline, aminoglycosides and their combinations. However, in a recent systematic …
Treatment Options for K. pneumoniae, P. aeruginosa and A. baumannii Co-resistant to Carbapenems, Aminoglycosides, Colistin and Tigecycline. An Approach Based …
The management of carbapenem-resistant infections is often based on colistin, tigecycline,
aminoglycosides and their combinations. However, in a recent systematic review we found …
aminoglycosides and their combinations. However, in a recent systematic review we found …